跳至主要内容
临床试验/IRCT2013111815436N1
IRCT2013111815436N1已完成3 期

Evaluating the effect of combined ginger and quince on dyspepsia in cancer patients undergoing concurrent chemotherapy and radiotherapy

Simorgh-e-Hekmat knowledge-base institute0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 139 years(—)
性别
All

入选标准

  • suffering from cancer; definitely diagnosed by a pathologist; 18?? year-old or more; under chemotherapy treatments; simultaneous radiotherapy treatments inducing ?nausea and vomiting such as whole body or upper abdomen. Exclusion criteria: Warfarin and Heparin ?treatment; ASA consuming more than 80 mg; history of? blood disorders; history of severe thrombocytopenia; allergy to ginger or consuming it during the ?past week; gastro-intestinal cancers; having nausea and vomiting induced by factors except ?chemotherapy or radiotherapy such as CNS tumors, HTN, renal failure or hepatic disorders; gastrointestinal ?problems like gastric or peptic ulcers; forgetting the use of capsules three consecutive times or more.

排除标准

  • 未提供

研究者

发起方
Simorgh-e-Hekmat knowledge-base institute

相似试验

The effect of ginger-quince compound on dyspepsia ... | 临床试验